IPO registrations (S-1, F-1) · Registrants

Ocugen, Inc.

SEC CIK
1372299 · filings on EDGAR ↗
Name on the registration
HISTOGENICS CORP
Former names
HISTOGENICS CORP (2006–2019)
Registration
Form S-1, first filed 2014-10-07, last 2014-12-02; 1 initial registration, 4 amendments
Outcome
Final prospectus filed 2014-12-03; declared effective 2014-12-02
Industry (SIC)
Biological Products, (No Diagnostic Substances) 2836
Incorporated in
DE
Business address
11 GREAT VALLEY PARKWAY, Malvern, PA 19355
Ticker
OCGN (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
Ocugen, Inc. on the corporate pages

Offering terms

Final price
$11.00 per share (424B4 filed 2014-12-03, an initial public offering)
Shares sold
5,909,091
Gross proceeds
$65,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol HSGX
Lead underwriters
Cowen
Syndicate
Needham & Company; Canaccord Genuity; BTIG

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 8

FiledFormWhat it isName as filedEDGAR
2014-10-07S-1S-1 (registration)HISTOGENICS CORP0001193125-14-365761 ↗
2014-11-07S-1/AS-1/A (amendment)HISTOGENICS CORP0001193125-14-403509 ↗
2014-11-14S-1/AS-1/A (amendment)HISTOGENICS CORP0001193125-14-413126 ↗
2014-11-26S-1/AS-1/A (amendment)HISTOGENICS CORP0001193125-14-427246 ↗
2014-12-02S-1/AS-1/A (amendment)HISTOGENICS CORP0001193125-14-430664 ↗
2014-12-02EFFECTEFFECT (declared effective)HISTOGENICS CORP9999999995-14-003555 ↗
2014-12-03424B4424B4 (final prospectus)HISTOGENICS CORP0001193125-14-432202 ↗
2016-11-04EFFECTEFFECT (declared effective)HISTOGENICS CORP9999999995-16-006154 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2014-12-02S-1/Aregistration statement$0.015,654$560primary document; price sentence, shares headline, proceeds computeddocument ↗
2014-12-03424B4final prospectus$11.005,909,091$65,000,000Nasdaq HSGX4primary document; price sentence, shares headline, proceeds table, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
AKKARAJU SRINIVASTenPercentOwner22014
Baltzell Joshua JDirector52014–2018
Gridley AdamDirector,OfficerPresident and CEO; See Remarks82014–2018
HEALY JAMESTenPercentOwner22014
JOHNSON JOHNDirector52014–2018
Kennedy Stephen RichardOfficerChief Operating Officer; Chief Technology Officer; EVP and COO; Senior VP of Operations; SVP of Technical Operations82014–2018
Kong GarhengDirector52014–2018
Lewis MichaelDirector; Director,TenPercentOwner112014–2019
Lynch NancyOfficerChief Medical Officer12014
McArdle KevinOfficerChief Financial Officer22014–2015
Mehra AnandTenPercentOwner22014
POWELL MICHAELTenPercentOwner22014
RAKIN KEVINDirector102014–2019
Sofinnova Management VIII, L.L.C.TenPercentOwner22014
Sofinnova Venture Partners VIII, L.P.TenPercentOwner22014
SPLIT ROCK PARTNERS II, LPTenPercentOwner42014–2017
SPLIT ROCK PARTNERS II MANAGEMENT, LLCTenPercentOwner42014–2017
Wilmslow Estates LtdTenPercentOwner72014–2019
INTREXON CORPTenPercentOwner22014–2019
KIRK RANDAL JTenPercentOwner22014–2019
GILL DAVID NDirector102015–2018
Lieber Jonathan IOfficerChief Financial Officer72015–2018
Matthews GloriaOfficerChief Medical Officer42015–2017
Haut DonaldOfficerChief Business Officer42017–2018
Washer Susan B.Director22018
Kelley Lynne EOfficerChief Medical Officer32018
Hood David C.Director12019person page Fuzzy
Subramanian SanjayOfficerChief Financial Officer172019–2022
Zhang JungeDirector232019–2026
Musunuri ShankarDirector,OfficerChief Executive Officer272019–2026
Arumugham RasappaOfficerChief Scientific Officer32019–2020
Beck KellyOfficerVice President32019–2020
JORGENSEN DANIELOfficerChief Medical Officer32019–2020
Kompella UdayDirector182019–2026
Kumar RameshDirector132019–2023
Leo FrankDirector22019–2020
Tammara VijayOfficerSenior Vice President; Vice President72019–2021
Taspolatoglu SuhaDirector32019–2021
Potti ManishDirector82019–2021
Castillo KirstenDirector142020–2026
Fernandes PrabhavathiDirector92020–2024
Crespo JessicaOfficerCAO/SVP, Finance42022–2023
WHITTINGTON MARNA CDirector52022–2024
Upadhyay ArunOfficerChief Scientific Officer; See Remarks102023–2025
Vu Quan AnhOfficerCFO/CBO12023
Breininger MichaelOfficerSee Remarks12024
Qamar HumaOfficerChief Medical Officer32024–2025
Ramachandran RameshOfficerChief Accounting Officer32024–2026
Chandrasekhar SatishchandranDirector42025–2026
Coleman BlaiseDirector32025–2026
Johnson-Greene Treerita EssalimaOfficerChief Financial Officer22026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2020-05-07Ocugen, Inc.Biotechnology$395$39511
2020-05-07Ocugen, Inc.Biotechnology$14,283,724$14,283,72461
2016-10-12HISTOGENICS CORPOther Health Care$30,000,001$30,000,001201
2014-01-06HISTOGENICS CORPOther Health Care$20,647,968$10,323,988171

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Form D issuerOcugen, Inc.PAForm D private offeringsCIK (EXACT)
SEC filerOcugen, Inc.SEC filers (EDGAR)CIK (EXACT)
Business registrationOcugen, Inc.State business registriesname and state
Lobbying clientOCUGEN INCFederal lobbying (LDA)name and state
Lobbying clientOCUGEN INC.Federal lobbying (LDA)name and state
Lobbying clientOCUGEN, INC.Federal lobbying (LDA)name and state
Lobbying clientOCUGEN, INC.Federal lobbying (LDA)name and state
Person pageDavid C HoodPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Biological Products, (No Diagnostic Substances), PA first:

More with this interest.

In other datasets, the same topic (Health) in PA:

Interests: Biological Products, (No Diagnostic Substances) · Health